Praxis Precision Medicines Inc (PRAX)

May 05, 2026

Praxis gives 21 new employees stock awards tied to hiring - Stock Titan

May 05, 2026

May 05, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 05, 2026

May 05, 2026

Praxis Precision Medicines Inc expected to post a loss of $3.57 a shareEarnings Preview - TradingView

May 05, 2026

May 04, 2026

Praxis Precision Medicines (PRAX.US) will release its earnings report before the market opens on May 7. - Moomoo

May 04, 2026

May 04, 2026

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference - The Manila Times

May 04, 2026

May 04, 2026

Praxis maps out two investor events in May, starting with Q1 results - Stock Titan

May 04, 2026

May 03, 2026

Wolfe Research initiates coverage of Praxis Precision Medicines (PRAX) with outperform recommendation - MSN

May 03, 2026

May 03, 2026

Praxis (PRAX) Aligns Pay With Ulixacaltamide Progress Is Incentive Design Now a Key Edge? - Yahoo Finance

May 03, 2026

May 03, 2026

A Look At Praxis Precision Medicines (PRAX) Valuation After Strong Long Term Shareholder Returns - Yahoo Finance

May 03, 2026

Apr 30, 2026

Praxis (NASDAQ: PRAX) details 2026 virtual meeting, director slate and Say-on-Pay - Stock Titan

Apr 30, 2026

Apr 30, 2026

Vanguard (NASDAQ: PRAX) reports 1.42M shares, 5.09% stake in Praxis - Stock Titan

Apr 30, 2026

Apr 30, 2026

PRAX Stock Price, Quote & Chart | PRAXIS PRECISION MEDICINES I (NASDAQ:PRAX) - ChartMill

Apr 30, 2026

Apr 29, 2026

LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $567 - Moomoo

Apr 29, 2026

Apr 29, 2026

Analysts Project Growth for Praxis Precision Medicines Biotech Stock - HarianBasis.co

Apr 29, 2026

Apr 29, 2026

Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide - Insider Monkey

Apr 29, 2026

Apr 29, 2026

Moody Aldrich Partners LLC Buys New Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat

Apr 29, 2026

Apr 29, 2026

Pictet Asset Management Holding SA Makes New $71.09 Million Investment in Praxis Precision Medicines, Inc. $PRAX - MarketBeat

Apr 29, 2026

Apr 29, 2026

Praxis Precision Medicines stock drops 2.74% as positive Phase 3 Essential Tremor data shared at AANAM - Traders Union

Apr 29, 2026

Apr 28, 2026

How Investors May Respond To Praxis (PRAX) Securing Dual FDA Reviews For Key Neurology Drug Candidates - simplywall.st

Apr 28, 2026

Apr 28, 2026

10 Best Biotech Stocks with Highest Upside Potential - Insider Monkey

Apr 28, 2026

Apr 27, 2026

Praxis Precision Medicines Prepares for Major FDA Decisions in 2026 - HarianBasis.co

Apr 27, 2026

Apr 27, 2026

Praxis Precision Medicines Inc. (PRAX): Rare Triple-Catalyst Setup in Neurology - Insider Monkey

Apr 27, 2026

Apr 27, 2026

M&T Bank Corp Purchases Shares of 12,586 Praxis Precision Medicines, Inc. $PRAX - MarketBeat

Apr 27, 2026

Apr 26, 2026

Billionaire Joe Edelman’s 5 Stock Picks with Huge Upside Potential - Insider Monkey

Apr 26, 2026

Apr 26, 2026

Praxis Precision shares rally on price target hikes: Analyst sees upside as high as 100% for stock - MSN

Apr 26, 2026

Apr 26, 2026

Praxis Precision gains as lead asset accepted for FDA review - MSN

Apr 26, 2026

Apr 25, 2026

(PRAX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Apr 25, 2026

Apr 24, 2026

JonesTrading Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $441 - Moomoo

Apr 24, 2026

Apr 24, 2026

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Apr 24, 2026

Apr 24, 2026

Praxis Precision Medicines (PRAX) Projected to Post Earnings on Friday - MarketBeat

Apr 24, 2026

Apr 23, 2026

Praxis Precision Medicines (PRAX): One of the Best Upside Stocks - Insider Monkey

Apr 23, 2026

Apr 23, 2026

Praxis rises on elsunersen data for SCN2A encephalopathy in children - MSN

Apr 23, 2026

Apr 23, 2026

PRAX (Praxis Precision Medicines Inc.) shares rise nearly 7 percent despite wider than expected Q4 2025 per share loss.Stability Report - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026

Apr 22, 2026

5 Best Upside Stocks to Buy According to Analysts - Insider Monkey

Apr 22, 2026

Apr 22, 2026

LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $567 - Moomoo

Apr 22, 2026

Apr 21, 2026

Praxis Precision Medicines (PRAX) Is Up 8.1% After FDA Accepts Ulixacaltamide NDA for Essential Tremor - simplywall.st

Apr 21, 2026

Apr 21, 2026

Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,200 - Moomoo

Apr 21, 2026

Apr 18, 2026

LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $545 - 富途牛牛

Apr 18, 2026

Apr 18, 2026

Massachusetts Financial Services Co. MA Purchases New Shares in Praxis Precision Medicines, Inc. $PRAX - MarketBeat

Apr 18, 2026

Apr 17, 2026

Truist Financial Remains Bullish on Praxis Precision Medicines (PRAX) - MSN

Apr 17, 2026

Apr 16, 2026

Needham Raises Price Target for Praxis Precision Medicine (PRAX) - GuruFocus

Apr 16, 2026

Apr 16, 2026

Why is Praxis Precision stock soaring Tuesday? - MSN

Apr 16, 2026

Apr 16, 2026

Praxis Precision Medicines (NASDAQ:PRAX) Shares Down 5.1%Time to Sell? - MarketBeat

Apr 16, 2026

Apr 15, 2026

Deutsche Bank Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $437 - Moomoo

Apr 15, 2026